High Court Ruling Dooms Investor Class Status Bid, Allergan Says

June 22, 2021, 8:02 PM

Allergan PLC wants to use a new U.S. Supreme Court ruling on class certification in an unrelated securities case to block its investors from moving forward with a lawsuit as a group, the company told a federal judge in New York.

Investors who say Allergan misled them about breast implant safety should be denied class certification under the Supreme Court’s ruling, the pharmaceutical company said in a letter to the U.S. District Court for the Southern District of New York.

The high court on Monday sent a class case against Goldman Sachs Group Inc. back to a lower court for ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.